Solana Company (formerly Helius Medical Technologies) — Cyborg Score 5/10
Mixed
Digital Asset Treasury / Crypto Accumulation (primary); Medical Device - Neurotech (legacy)
Strategic Profile
As an independent treasury company, HSDT's mission is to support the growth and security of tokenized networks by serving as a long-term holder of SOL, in addition to continuing the development of its neurotech and medical device operations. The company's combined Solana holdings and cash holdings exceed $525 million of value. The company leverages public capital markets access to accumulate yield-generating crypto assets while maintaining a portfolio of neurotech medical devices for neurological conditions.
Cyborg Score Rationale
The company demonstrates strong execution on its Solana treasury strategy with substantial accumulated assets and institutional backing, but faces significant volatility as a single-asset treasury dependent on SOL price movements and crypto market conditions. Legacy neurotech operations show clinical progress but remain unprofitable and operationally immaterial to valuation.
Top Insights
Q3 2025 revenue was $697,000 (including $342,000 staking rewards) with net loss of $352.8M, reflecting digital asset volatility.
Combined Solana and cash holdings exceed $525 million, surpassing initial $508M capital raise in under three weeks.
Aetna Healthcare approved $18,350 reimbursement for PoNS device, making it the third major payer after Anthem and United.
Company plans to tokenize HSDT shares on Superstate's Opening Bell platform on Solana blockchain, enabling 24/7 trading and real-time settlement.
Named Competitors
Bitcoin Accumulation Strategy — Large-cap BTC treasury company with similar corporate treasury model
Digital Asset Treasury — Bitcoin and crypto mining company with treasury strategy
Portable Neuromodulation Stimulator (PoNS) — Non-invasive neuromodulation for neurological deficits
Recent Developments
(November 2025) Announced tokenization of HSDT shares on Solana blockchain through Superstate partnership
(October 2025) Entered staking agreements with Helius and Twinstake for non-custodial SOL staking services
(June 2025) Secured Aetna Healthcare reimbursement authorization for PoNS device at $18,350
Open the full interactive Solana Company (formerly Helius Medical Technologies) report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.